# Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav

> **NCT00519753** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 522 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Travoprost 0.004%/timolol maleate 0.5% fixed combination ophthalmic solution (DuoTrav)

## Key facts

- **NCT ID:** NCT00519753
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 522 (ACTUAL)
- **Last updated:** 2016-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00519753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00519753, "Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00519753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*